# Bioavailability and Pharmacokinetics of Calcium Dobesilate (Doxium®) in the Nasal Mucosal Tissue, Saliva and Blood of Treated Patients

> **NCT04922996** · — · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 14 (actual)

## Conditions studied

- Biological Availability

## Interventions

- **DRUG:** Calcium Dobesilate

## Key facts

- **NCT ID:** NCT04922996
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-15
- **Primary completion:** 2021-05-26
- **Final completion:** 2021-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04922996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04922996, "Bioavailability and Pharmacokinetics of Calcium Dobesilate (Doxium®) in the Nasal Mucosal Tissue, Saliva and Blood of Treated Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04922996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*